Therefore, miR-671-5p suppresses the expression of FGFR2, inhibits the MAPK-ERK and PI3K-AKT signaling pathways to block the cell cycle, and inhibits the proliferation, invasion and migration of ESCC cells and progression of ESCC (Fig. 8). Here, AKT1 is linked to esophageal squamous cell carcinoma.